Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Novel 2‐Aminothiazole Derivatives as Potential FOXM1 Inhibitors for Triple‐Negative Breast Cancer Therapy and Structure‐Activity Relationship

Documenti analoghi

• Novel benzothiazole/benzothiazole thiazolidine‐2,4‐dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies
  di: Khaled A. N. Abusharkh, et al.
  Pubblicazione: (2024)
• Repurposing of FDA‐Approved Drugs as Acetylcholinesterase Inhibitors for Alzheimer's Disease: A Combined In Silico and In Vitro Evaluation and Structure–Activity Relationship
  di: Merve Sıkık, et al.
  Pubblicazione: (2025)
• Dynorphin A Inhibits the Proliferation, Migration, Invasion, and Stemness of Triple Negative Breast Cancer Cells
  di: Xiaojiao Liu, et al.
  Pubblicazione: (2026)
• β‐Elemene Suppresses Proliferation, Migration, and Stemness in Triple‐Negative Breast Cancer by Inhibiting SIX‐1
  di: Jia Liu, et al.
  Pubblicazione: (2025)
• Puerarin Decreases the Expression of FUS‐Dependent MAPK4 to Inhibit the Development of Triple‐Negative Breast Cancer
  di: Jian Guo, et al.
  Pubblicazione: (2024)